ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 38 filers reported holding ETON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,134,226 | +27.1% | 2,430,270 | +6.4% | 3.30% | +72.8% |
| Q2 2023 | $7,974,650 | -5.2% | 2,285,000 | +4.6% | 1.91% | -24.3% |
| Q1 2023 | $8,412,250 | +37.5% | 2,185,000 | +0.7% | 2.52% | +18.4% |
| Q4 2022 | $6,119,400 | +15.6% | 2,170,000 | -13.9% | 2.13% | -2.7% |
| Q3 2022 | $5,294,000 | -17.9% | 2,521,000 | +2.4% | 2.19% | -24.8% |
| Q2 2022 | $6,452,000 | -37.8% | 2,462,500 | +3.5% | 2.91% | -9.7% |
| Q1 2022 | $10,374,000 | +1.4% | 2,379,275 | -0.2% | 3.22% | +48.5% |
| Q4 2021 | $10,232,000 | -34.3% | 2,385,000 | -22.8% | 2.17% | -25.4% |
| Q3 2021 | $15,564,000 | -46.9% | 3,088,100 | -16.4% | 2.91% | -40.3% |
| Q2 2021 | $29,310,000 | -0.9% | 3,692,600 | -8.6% | 4.87% | +12.1% |
| Q1 2021 | $29,573,000 | -10.0% | 4,040,000 | 0.0% | 4.34% | +1.3% |
| Q4 2020 | $32,845,000 | +14.2% | 4,040,000 | +11.0% | 4.29% | -23.7% |
| Q3 2020 | $28,756,000 | +45.0% | 3,640,000 | 0.0% | 5.62% | +40.4% |
| Q2 2020 | $19,838,000 | +32.9% | 3,640,000 | 0.0% | 4.01% | +1.3% |
| Q1 2020 | $14,924,000 | +41.1% | 3,640,000 | +147.7% | 3.96% | +90.5% |
| Q4 2019 | $10,580,000 | +43.7% | 1,469,456 | +26.1% | 2.08% | -22.0% |
| Q3 2019 | $7,363,000 | -13.3% | 1,165,000 | +8.4% | 2.66% | +2.9% |
| Q2 2019 | $8,493,000 | +38.8% | 1,075,000 | +40.6% | 2.59% | +52.8% |
| Q1 2019 | $6,118,000 | +91.2% | 764,773 | +46.2% | 1.69% | +41.9% |
| Q4 2018 | $3,200,000 | – | 523,000 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|